or
forgot password

    • cancer clinical trials in reading, PA

    • Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Pancreatic Cancer
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Colorectal Cancer
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Reading Hospital and Medical Center

    Trial Locations
    Reading Hospital and Medical Center
    St. Joseph Medical Center
    Anal Cancer
    Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Gestational Trophoblastic Tumor
    Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Diarrhea, Radiation Enteritis
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Breast Cancer
    Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Leukemia
    Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Kidney Cancer
    S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Lung Cancer
    Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Anemia, Head and Neck Cancer
    Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Head and Neck Cancer
    Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Head and Neck Cancer
    External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Prostate Cancer
    Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Colorectal Cancer
    Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Brain and Central Nervous System Tumors
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy
    Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Esophageal Cancer, Gastric Cancer
    Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Stage III Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage IVA Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma, Stage IIC Adult Soft Tissue Sarcoma
    Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Head and Neck Cancer, Lung Cancer
    Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Multiple Myeloma and Plasma Cell Neoplasm
    Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Lymphoma
    Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Colorectal Cancer
    Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Lung Cancer
    Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Lung Cancer
    Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Sarcoma
    Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Sarcoma
    Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Metastatic Cancer, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Kidney Cancer
    Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Carcinoma of Unknown Primary
    Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Lung Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Extensive Stage Small Cell Lung Cancer
    Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
    Reading Hospital and Medical Center

    Trial Locations
    Reading Hospital and Medical Center
    St. Joseph Medical Center
    Pancreatic Cancer
    Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Lung Cancer
    Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Vulvar Cancer
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Pancreatic Cancer
    Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Anal Cancer, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Enteritis
    Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer
    Reading Hospital and Medical Center

    Trial Locations
    Reading Hospital and Medical Center
    St. Joseph Medical Center
    Breast Cancer
    Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer
    St. Joseph Medical Center

    Trial Locations
    St. Joseph Medical Center
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Lung Cancer
    A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin
    Berks Hematology-Oncology Associates Ltd.
    Reading, Pennsylvania 19612
    Diffuse Large-Cell Lymphoma
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Brain and Central Nervous System Tumors
    Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Colorectal Cancer
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Esophageal Cancer
    G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Lung Cancer
    Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer
    The Reading Hospital and Medical Center
    Reading, Pennsylvania 19610
    Lung Cancer, Non Small Cell Lung Cancer
    Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Head and Neck Cancer
    Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Endometrial Cancer
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Colorectal Cancer, Metastatic Cancer